Anorexia nervosa, obsessional behavior, and serotonin

Psychopharmacology Bulletin

Volumn 33, Issue 3, 1997, Pages 335-344

  Kaye, Walter H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anorexia; Obsessions; Perfectionism; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANOREXIA NERVOSA; CEREBROSPINAL FLUID LEVEL; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; OBSESSION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELAPSE; REVIEW;

ANOREXIA NERVOSA; BRAIN; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN;

EID: 0030882932     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association, 1994.
2. Ananth, J; Pecknold, JC; Van der Steen, N; and Engelsmann, F. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 5:257-262, 1981.
3. Anderson, IM; Parry-Billings, M; Newsholme, EA; Fairburn, CG; and Cowen, PJ. Dieting reduces plasma tryptophan and alters brain serotonin function in women. J. Psychol. Med. 20:785-791, 1990.
4. Asbert, M; Traskman, L; and Thoren, P. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch. Gen. Psychiatry 33:1193-1197, 1976.
5. Baer, L, and Jenike, MA. Personality disorders in obsessive compulsive disorder. Psychiatr. Clin. North Am. 15(4):803-812, 1992.
6. Barr, LC; Goodman, WK; Price, LH; McDougle, CJ; and Charney, DS. The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies. J. Clin. Psychiatry 53(4 Suppl.):17-28, 1992.
7. Bastiani, AM; Altemus, AM; Pigott, TA; Rubenstein, C; Weltzin, TE; and Kaye, WH. Comparison of obsessions and compulsions in patients with anorexia nervosa and obsessive compulsive disorder. Biol. Psychiatry 39(11):966-969, 1996.
8. Bastiani, AM; Rao, R; Weltzin, T; and Kaye, WH. Perfectionism in anorexia nervosa. Int. J. Eat. Disord. 17(2):147-152, 1995.
9. Black, DW; Noyesm, R, Jr; Pfohl B; Goldstein, RB; and Blum, N. Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives. Am. J. Psychiatry 150(8):1226-1232, 1993.
10. Blundell, JE. Serotonin and appetite. Neuropharmacology 23:1537-1551, 1984.
11. Braun, DL; Sunday, SR; and Halmi, KA. Psychiatric comorbidity in patients with eating disorders. Psychol. Med. 24:859-867, 1994.
12. Brewerton, TD; Hard, LD; and Bishop, ER. The tridimensional personality questionnaire in eating disorder patients. Int. J. Eat. Disord. 14(2):213-218, 1993.
13. Brown, GL; Goodwin, FK; Ballenger, JC; Goyer, PF; and Major, LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1:131-139, 1979.
14. Bulik, CM; Sullivan, PF; Weltzin, TE; and Kaye, WH. Temperament in eating disorders. Int. J. Eat. Disord. 17(3):251-261, 1995.
15. Casper, RC. Personality features of women with good outcome from restricting anorexia nervosa. Psychosom. Med. 52:156-170, 1990.
16. Casper, RC; Hedeker, D; and McClough, JF. Personality dimensions in eating disorders and their relevance for subtyping. J. Am. Acad. Child Adolesc. Psychiatry 31(5):830-840, 1992.
17. Charney, DS; Woods, SW; Goodman, WK; and Heninger, GR. Serotonin function in anxiety. Psychopharmacol. 92:14-24, 1987.
18. Cloninger, CR. Neurogenic adaptive mechanism in alcoholism. Science 235:410-416, 1987.
19. Crisp, AH; Lacey, JH; and Crutchfield, M. Clomipramine and "drive" in people with anorexia nervosa. Br. J. Psychiatry 150:355-358, 1987.
20. Dally, P. Anorexia Nervosa. Philadelphia, PA: Grune & Stratton, 1969.
21. DuBois, F. Compulsion neurosis with cachexia. Am. J. Psychiatry 106:107-115, 1949.
22. Eckert, ED; Goldberg, SC; Halmi, KA; Casper, RC; and Davis, JM. Depression in anorexia nervosa. Psychol. Med. 12:115-122, 1982.
23. Ferguson, JM. Treatment of an anorexia nervosa patient with fluoxetine (Letter). Am. J. Psychiatry 144:1239, 1987.
24. Frost, RO; Marten, P; Lahart, C; and Rosenblat, R. The dimensions of perfectionism. Cog. Ther. Res. 14(5):449-468, 1990.
25. Garner, DM; Olmstead, MP; and Polivy, J. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int. J. Eat. Disord. 2:15-34, 1983.
26. Gartner, AF; Marcus, RN; Halmi, K; and Loranger, AW. DSM-III-R personality disorders in patients with eating disorders. Am. J. Psychiatry 146(12):1585-1591, 1989.
27. Gibbons, JL; Barr, GA; Bridger, WH; and Leibowitz, SF. Manipulations of dietary tryptophan: Effects on mouse killing and brain serotonin in the rat. Brain Res. 169:139-153, 1979.
28. Gillberg, IC; Rastam, M; and Gillberg, C. Anorexia nervosa 6 years after onset: Part I. Personality disorders. Compr. Psychiatry 36(1):61-69, 1995.
29. Goodman, WK; Price, LH; Rasmussen, SA; Delgado, PL; Heninger, GR; and Charney, DS. Efficacy of fluvoxamine in obsessive-compulsive disorders. Arch. Gen. Psychiatry 46:36-44, 1989a.
30. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Delgado, P; Heninger, G; and Charney, D. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): II. Validity. Arch. Gen. Psychiatry 46:1012-1016, 1989b.
31. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Fleischmann, R; Hill, C; Heninger, G; and Charney, D. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): I. Development, use and reliability. Arch. Gen. Psychiatry 46:1006-1011, 1989c.
32. Gwirtsman, HE; Guze, BH; Yager, J; and Gainsley, B. Fluoxetine treatment of anorexia nervosa: An open clinical trial. J. Clin. Psychiatry 51:378-382, 1990.
33. Halmi, KA; Eckert, ED; LaDu, TJ; and Cohen, J. Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch. Gen. Psychiatry 43:177-181, 1986.
34. Halmi, KA; Eckert, E; Marchi, P; Sampugnaro, V; Apple, R; and Cohen, J. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch. Gen. Psychiatry 48:712-718, 1991.
35. Hendren, RL. Depression in anorexia nervosa. J. Am. Acad. Child Psychiatry 22:59-62, 1983.
36. Herzog, DB; Keller, MB; Lavori, PW; Kenny, GM; and Sacks, NR. The prevalence of personality disorders in 210 women with eating disorders. J. Clin. Psychiatry 53(5):147-152, 1992.
37. Holden, N. Is anorexia nervosa an obsessive-compulsive disorder? Br. J. Psychiatry 157:1-5, 1990.
38. Holland, AJ; Hall, A; Murray, R; Russell, GFM; and Crisp, AL. Anorexia nervosa: A study of 34 twin pairs. Br. J. Psychiatry 145:414-419, 1984.
39. Hollander, E; DeCaria, C; Gully, R; Nitescu, A; Suckow, RF; Gorman, JM; Klein, DF; and Liebowitz, MR. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to metachloro-phenylpiperazine in obsessive-compulsive disorder. Psychiatry Res. 36:1-17, 1991.
40. Hollander, E; Liebowitz, MR; Winchel, R; Klumker, A; and Klein, D. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am. J. Psychiatry 146:768-770, 1989.
41. Howard, JL, and Pollard, GT. The geller conflict test: A model of anxiety and a screening procedure for anxiolytics. In: Kanin, I, and Usdin, E, eds. Animal Models in Psychiatry and Neurology. New York: Pergamon Press, 1977. pp. 269-277.
42. Hsu, LKG. Outcome of anorexia nervosa: A review of the literature, 1954-1978. Arch. Gen. Psychiatry 37:1041-1046, 1980.
43. Hsu, L; Chesler, B; and Santhouse, R. Bulimia nervosa in eleven sets of twins: A clinical report. Int. J. Eat. Disord. 9(3):275-282, 1990.
44. Hudson, JI; Pope, HG; Jonas, JM; and Yurgelun-Todd, D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res. 9:345-354, 1983.
45. Jenike, MA; Buttolph, L; Baer, L; Ricciardi, J; and Holland, A. Open trial of fluoxetine in obsessive-compulsive disorder. Am. J. Psychiatry 146:909-911, 1989.
46. Kahn, RS; Van Praag, MH; and Wetzler, RS. Serotonin and anxiety revisited. Biol. Psychiatry 23:189-208, 1988.
47. Kay, DW, and Leigh, D. The natural history, treatment, and prognosis of anorexia nervosa, based on a study of 38 patients. J. Ment. Sci. 100:411-431, 1954.
48. Kaye, WH; Gwirtsman, HE; George, DT; and Ebert, MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration: Does elevated CSF 5-HIAA correlate with rigid and obsessive behavior? Arch. Gen. Psychiatry 48(6):556-562, 1991.
49. Kaye, WH; Gwirtsman, HE; George, DT; Jimerson, DC; and Ebert, MH. CSF 5-HIAA concentrations in anorexia nervosa: Reduced values in underweight subjects normalize after weight gain. Biol. Psychiatry 23:102-105, 1988.
50. Kaye, WH; Weltzin, TE; Hsu, LKG; and Bulik, C. An open trial of fluoxetine in patients with anorexia nervosa. J. Clin. Psychiatry 52:464-471, 1992a.
51. Kaye, WH; Weltzin, TE; Hsu, LKG; Bulik, CM; McConaha, C; and Sobkiewicz, T. Patients with anorexia nervosa have elevated scores on the Yale-Brown Obsessive-Compulsive scale. Int. J. Eat. Disord. 12:57-62, 1992b.
52. Kendler, KS; Walters, EE; Neale, MC; Kessler, RC; Heath, AC; and Eaves, LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch. Gen. Psychiatry 52(5):374-383, 1995.
53. Keys, A. The Biology of Human Starvation. Minneapolis, MN: University of Minnesota Press, 1950.
54. King, A. Primary and secondary anorexia nervosa syndromes. Br. J. Psychiatry 109:470-479, 1963.
55. Kleifield, EI; Sunday, S; Hurt, S; and Halmi, KA. The Tridimensional Personality Questionnaire: An exploration of personality traits in eating disorders. J. Psychiatr. Res. 28(5):413-423, 1994.
56. Leibowitz, SF, and Shor-Posner, G. Brain serotonin and eating behavior. Appetite 7:1-14, 1986.
57. Leysen, JE; Gommeren, W; and Van Gompel, P. Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long acting serotonin-S2 antagonist. Mol. Pharmacol. 27:600-611, 1985.
58. Linnoila, M; Virkkunen, M; Scheinin, M; Nuutila, A; Rimon, R; and Goodwin, FK. Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 33:2609-2614, 1983.
59. Mavissakalian, MR; Hamann, MS; Abou Haidar, S; and de Groot, CM. DSM-III personality disorders in generalized anxiety, panic/ agoraphobia, and obsessive-compulsive disorders. Compr. Psychiatry 34(4):243-248, 1993.
60. Messing, RB; Fisher, LA; Phebus, L; and Lytle, LD. Interaction of diet and drugs in the regulation of brain 5-hydroxy indoles and the response to painful electric shock. Life Sci. 18:707-714, 1976.
61. Morgan, H, and Russell, GFM. Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four-year followup study of 41 patients. Psychol. Med. 5:355-371, 1975.
62. Norris, DL. Clinical diagnostic criteria for primary anorexia nervosa. South African Med. J. 56:987-993, 1979.
63. Palmer, HD, and Jones, MS. Anorexia nervosa as a manifestation of compulsive neurosis. Arch. Neurol. Psychiatry 41:856-860, 1939.
64. Pasquale, L; Sciuto, G; Cocchi, S; Ronchi, P; and Bellodi, L. A family study of obsessive compulsive, eating and mood disorders. Eur. Psychiatry 9:33-38, 1994.
65. Perse, TL; Greist, JH; Jefferson, JW; Rosenfeld, R; and Dar, R. Fluvoxamine treatment of obsessive-compulsive disorder. Am. J. Psychiatry 144:1543-1548, 1987.
66. Pfohl, B, and Blum, N. Obsessive-compulsive personality disorder. In: Livesley, WJ, ed. The DSM-IV Personality Disorder. New York, NY: The Guilford Press, 1995. pp. 261-276.
67. Piran, N; Lerner, P; Garfinkel, P; Kennedy, S; and Brouillette, C. Personality disorders in anorexic patients. Int. J. Eat. Disord. 7:589-599, 1988.
68. Rothenberg, A. Differential diagnosis of anorexia nervosa and depressive illness: A review of 11 studies. Comp. Psychiatry 29:427-432, 1988.
69. Rothenberg, A. Eating disorder as a modern obsessive-compulsive syndrome. Psychiatry 49:45-53, 1986.
70. Russell, GF; Szmukler, GI; Dare, C; and Eisler, I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch. Gen. Psychiatry 44(12), 1047-1056, 1987.
71. Schweiger, V; Warnoff, M; Pahl, J; and Pirke, K. Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose and insulin plasma levels of anorectic patients. Metabolism 35(2):938-943, 1986.
72. Smart, DE; Beumont, PJV; and George, GCW. Some personality characteristics of patients with anorexia nervosa. Br. J. Psychiatry 128:57-60, 1976.
73. Solyom, LS; Freeman, RJ; and Miles, JE. A comparative psychometric study of anorexia nervosa and obsessive neurosis. Can. J. Psychiatry 27:282-286, 1982.
74. Soubrie, P. Reconciling the role of central serotonin neurosis in human and animal behavior. Behav. Brain. Sci. 9:319-363, 1986.
75. Srinivasagam, NM; Plotnicov, KH; Greeno, C; Weltzin, TE; Rao, R; and Kaye, WH. Persistent perfectionism, symmetry, and exactness in anorexia nervosa after long-term recovery. Am. J. Psychiatry 152(11):1630-1634, 1995.
76. Stonehill, E, and Crisp, AH. Psychotic characteristics of patients with anorexia nervosa before and after treatment and at followup 4-7 years later. J. Psychosom. Res. 21:187-193, 1977.
77. Strober, M. Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J. Psychosom. Res. 24:353-359, 1980.
78. Strober, M, and Katz, J. Depression in the eating disorders: A review and analysis of descriptive, family and biological findings. In: Garner, DM, and Garfinkel, PE, eds. Diagnostic Issues in Anorexia Nervosa and Bulimia Nervosa. New York: Brunner/Mazel, 1988. pp. 80-111.
79. Taylor, DP; Eison, MDS; and Riblet, LA. Pharmacological and clinical effects of buspirone. Pharmacol. Biochem. Behav. 23:687-694, 1985.
80. Thoren, P; Asberg, M; Cronholm, B; Jornestedt, L; and Traskman, L. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch. Gen. Psychiatry 37:1281-1285, 1980.
81. Toner, BB; Garfinkel, PE; and Garner, DM. Long-term followup of anorexia nervosa. Psych. Med. 48:520-529, 1986.
82. van Praag, HM. CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 2:977-978, 1983.
83. Volavka, J; Neziroglu, F; and Yaryura-Tobias, JA. Clomipramine and imipramine in obsessive-compulsive disorder. Psychiatry Res. 14:85-93, 1985.
84. Walters, EE, and Kendler, KS. Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample. Am. J. Psychiatry 152(1):64-71, 1995.
85. Wilckens, T; Schweiger, U; and Pirke, KM. Activation of 5-HT1c-receptors suppresses excessive wheel running induced by semistarvation in the rat. Psychopharmacol. 109:77-84, 1992.
86. Wilcox, JA. Abuse of fluoxetine by a patient with anorexia nervosa (Letter). Am. J. Psychiatry 144:1100, 1987.
87. Wonderlich, SA; Swift, W; Slotnick, HB; and Goodman, S. DSM-III-R personality disorders in eating-disorder subtype. Int. J. Eat. Disord. 9:607-616, 1990.
88. Wurtman, JJ, and Wurtman, RJ. Drugs that enhance central serotonergic transmission diminish elective carbohydrate consumption by rats. Life Sci. 24:895-903, 1979.
89. Zohar, J; Insel, TR; Zohar-Kadouch, RC; Hill, JL; and Murphy, DL. Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Arch. Gen. Psychiatry 45:167-172, 1988.